Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 13Neoplasms 3Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Cell Lung Cancer Extensive Stage 1Skin Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Pneumonia 1Peritoneal Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Lymphoma 1Lung Diseases, Interstitial 1Liver Neoplasms 1Leukemia 1Laryngeal Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Frailty 1

Interventions

Pemetrexed 2durvalumab 1Tretinoin 1Surgical Procedures, Operative 1Paclitaxel 1Observation 1Gemcitabine 1Cisplatin 1Carboplatin 1Bortezomib 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Observation × Thoracic × Clear all
NCT06743555 2026-04-28

SAVED LUNG

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 1 Not yet recruiting
14 enrolled
Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡